DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program
In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans
More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications
ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs
NCI Advisory Group, Other Cancer Meetings
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?









